This trial will test whether a prolonged nightly fasting intervention can prevent overweight and obese individuals with blood cancer from developing the disease.
1 Primary · 4 Secondary · Reporting Duration: Baseline to 4-months
40 Total Participants · 2 Treatment Groups
Primary Treatment: PROLONGED FASTING INTERVENTION · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: